Clin2
NCT06484075Possibly a fitRecruiting

Suvorexant for alcohol use disorder: brain effects

Healthy VolunteersAlcohol Use Disorder (AUD)

Treatments studied

Part of Mental health clinical trials.

This study tests whether the sleep medication suvorexant can help people with alcohol use disorder by looking at its effects on brain activity. Participants will stay in the hospital for about a month, take suvorexant or a placebo, and have brain scans.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
180 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You must be between 18 and 75 years old.
  • You must have a diagnosis of moderate or severe alcohol use disorder.
  • You must be willing to stay in the hospital for 28 to 40 days.
  • You must have had a drink within the last 7 days before starting the study.
  • You must have sleep problems, like trouble falling or staying asleep.
  • You must be able to have an MRI and PET brain scan (no metal in body, not claustrophobic, weight under 400 lbs).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06679062Recruiting· Phase 2
Suvorexant for alcohol use disorder and PTSD

This study tests whether the sleep medication suvorexant can help people with both alcohol use disorder and PTSD. If you're struggling with drinking, PTSD symptoms, and poor sleep, this trial may offer a new treatment option.

Los Angeles, California
NCT05829655Recruiting· Early Phase 1
Measuring drug cravings in people with opioid use disorder

This study tests whether the medication suvorexant can reduce drug cravings in people with opioid use disorder. You will take either suvorexant or a placebo and have your cravings measured in a safe setting.

Baltimore, Maryland
NCT06269627Recruiting· Phase 4
Brain activity study for alcohol use treatment

This trial tests how the medication acamprosate affects brain activity in people with moderate to severe alcohol use disorder. It may help researchers understand how this treatment works.

Bethesda, Maryland
NCT06326684Recruiting· Early Phase 1
Testing suvorexant for alcohol use disorder

This study tests whether the sleep medication suvorexant can help people with alcohol use disorder drink less. It involves a short stay where you'll receive either suvorexant or a placebo and then have alcohol.

Lexington, Kentucky
NCT07214207Recruiting· Phase 2
Testing a sleep medicine for alcohol use disorder and stress-related drinking

This trial tests whether a medicine called suvorexant, which is used for sleep, can help people with alcohol use disorder drink less, especially when stressed. You would receive the medicine or a placebo, and researchers will track your drinking and stress levels over several weeks.

Columbus, Ohio
NCT06655883Recruiting· Phase 3
Testing suvorexant for insomnia in people with opioid use disorder

This study tests whether the sleep medication suvorexant (Belsomra) can help people with opioid use disorder who also have trouble sleeping. If you are stable on medication for opioid use disorder and have not used opioids in the last month, this trial may be an option for you.

Garden Grove, California

Hear when a new Healthy Volunteers trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.